Health Care & Life Sciences » Biotechnology | Transgene

Transgene S.A. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,849.00
1,837.00
1,465.00
2,346.00
2,099.00
1,335
SG&A Expense
53,908.00
46,257.00
35,300.00
30,618.00
34,124.00
32,443
EBIT
50,128.00
-
36,226.00
30,180.00
33,934.00
33,005
Unusual Expense
-
-
7,536.00
148.00
-
-
Non Operating Income/Expense
99.00
775.00
489.00
1,446.00
849.00
33,512
Interest Expense
702.00
671.00
554.00
752.00
1,079.00
1,031
Pretax Income
50,731.00
49,004.00
44,592.00
29,519.00
35,685.00
398
Income Tax
8,803.00
8,711.00
7,855.00
6,253.00
5,355.00
5,749
Equity in Affiliates
930.00
823.00
1,172.00
917.00
1,944.00
2,675
Consolidated Net Income
42,858.00
41,116.00
37,909.00
24,183.00
32,274.00
8,026
Net Income
42,858.00
41,116.00
37,909.00
24,183.00
32,274.00
8,026
Net Income After Extraordinaries
42,858.00
33,676.00
29,444.00
23,159.00
32,274.00
8,026
Net Income Available to Common
42,858.00
48,556.00
46,374.00
25,207.00
32,274.00
8,026
EPS (Basic)
1.27
1.23
1.17
0.45
0.52
0.13
Basic Shares Outstanding
33,553.50
39,354.40
39,372.20
56,432.00
61,982.10
63,795.50
EPS (Diluted)
1.28
1.23
1.18
0.45
0.52
0.12
Diluted Shares Outstanding
33,553.50
39,354.40
39,372.20
56,432.00
61,982.10
64,540.60
EBITDA
47,204.00
44,926.00
33,590.00
28,143.00
32,025.00
31,108
Other Operating Expense
2,855.00
56.00
245.00
129.00
-
-
Non-Operating Interest Income
-
420.00
213.00
115.00
177.00
126

About Transgene

View Profile
Address
400 Boulevard Gonthier dAndernach
Strasbourg Alsace 67405
France
Employees -
Website http://www.transgene.fr
Updated 07/08/2019
Transgene SA is a biotechnology company, which engages in the research, development, and manufacture of immunotherapies for the treatment of cancer and infectious diseases. Its products include TG4010, Pexa-Vec, TG4001, TG6002, TG1050, and TG4040. The company was founded in December 1979 and is headquartered in Strasbourg, France.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.